OneThree Biotech redesigns drug discovery with biology-driven artificial intelligence to uncover new insights. Its platform predicts new potential therapeutics and pinpoints the mechanisms driving efficacy. It also integrates over 30 types of chemical, biological, and clinical data for each task that leads to a significant increase in accuracy, interpretability, and chance of clinical success. OneThree Biotech is a VC backed startup working to change how new medicines are discovered using biology-driven AI. We all know someone who’s been affected by cancer, and we’ve proven that our technology can help get life-saving treatments to patients faster (people.com/health/teacher-brain-tumor-week-to-live-now-thriving). Having already signed a set of Fortune 500 paying clients, we’re ramping up for our next phase of growth and are looking for a bold and self-motivated engineer to join us as we change healthcare for the better.
Total Funding: $2.5 M
Funding Stage: Seed
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2018
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at OneThree Biotech
OneThree Biotech - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups
OneThree Biotech - Manage Profile
World's Most Promising AI Startups
World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals
Get Started